Fig. 1: Positive (PPV) and negative predictive values (NPV) for patients with AS with AAU for centiles of genetic risk scores [10].

The prevalence of patients with both AS and AAU is assumed to be 0.3% among the general population, and 20% in AS patients attending rheumatology outpatient clinics.